Envoy Medical Income Statement (2021-2026) | COCH

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.06M0.02M0.08M0.06M0.08M0.10M0.06M0.07M0.06M0.04M0.05M0.08M0.04M0.07M0.04M
Cost of Revenue (Quarter)
0.11M0.15M0.17M0.16M0.19M0.23M0.15M0.24M0.19M0.16M0.23M0.23M0.20M0.21M0.31M
Gross Profit (Quarter)
-0.05M-0.13M-0.10M-0.10M-0.11M-0.14M-0.09M-0.18M-0.13M-0.12M-0.18M-0.16M-0.16M-0.14M-0.27M
Operating items
Research & Development (Quarter)
0.94M-2.65M0.37M0.38M0.40M-4.24M0.33M0.50M0.39M0.52M2.75M2.48M0.41M4.55M3.64M
Selling, General & Administrative (Quarter)
0.81M0.45M1.38M1.84M1.03M3.02M2.10M1.59M1.69M1.45M1.82M2.07M2.44M1.60M1.88M
Other Operating Expenses (Quarter)
1.07M2.99M0.96M1.49M0.90M0.11M5.13M2.10M2.31M2.04M8.04M0.10M0.58M0.59M2.90M0.31M-7.12M
Operating Expenses (Quarter)
1.07M2.99M0.96M1.49M0.90M1.85M2.93M3.85M4.54M3.46M6.82M1.34M4.92M5.03M4.59M5.15M5.15M5.75M6.46M-1.60M
Operating Income (Quarter)
-1.07M-2.99M-0.96M-1.49M-0.90M-1.80M-2.91M-3.77M-4.48M-3.38M-6.72M-4.88M-4.85M-4.97M-4.55M-5.11M-5.07M-5.71M-6.38M-5.96M
EBIT (Quarter)
-1.07M-2.99M-0.96M-1.49M-0.90M-1.80M-2.91M-3.77M-4.48M-3.38M-6.72M-4.88M-4.85M-4.97M-4.55M-5.11M-5.07M-5.71M-6.38M-5.96M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.02M0.01M0.01M0.04M0.56M1.93M3.59M3.37M0.53M
Other Non Operating Income (Quarter)
0.57M-6.97M-9.38M9.27M0.05M0.11M-0.01M-0.01M0.01M-0.02M-0.01M-0.00M0.01M-0.02M0.01M
Non Operating Income (Quarter)
0.46M-8.57M-9.48M-8.77M4.95M1.83M-1.39M0.91M-0.99M-0.07M0.11M-0.62M-0.77M-0.20M1.61M
Net income details
EBT (Quarter)
0.37M5.57M-4.72M12.46M3.20M6.22M-1.15M1.56M-1.02M-4.08M6.55M-4.98M-92.35M-1855.63M-4.93M-5.60M-5.69M-6.18M-6.38M-6.22M
Tax Provisions (Quarter)
0.11M0.53M0.86M0.84M0.12M
Profit After Tax (Quarter)
0.37M5.57M-4.72M-1.87M-1.24M-1.34M-11.48M-13.25M-13.34M1.56M-4.90M-6.27M-3.95M-5.96M-4.62M-6.24M-5.69M-6.48M-6.59M-5.70M
Income from Continuing Operations (Quarter)
0.37M5.57M-4.72M12.46M3.09M5.69M-2.01M0.72M-1.14M-4.08M6.55M-4.98M-92.35M-1855.63M-4.93M-5.60M-5.69M-6.18M-6.38M-6.22M
Consolidated Net Income (Quarter)
0.37M5.57M-4.72M12.46M3.09M5.69M-2.01M0.72M-1.14M-4.08M6.55M-4.98M-92.35M-1855.63M-4.93M-5.60M-5.69M-6.18M-6.38M-6.22M
Income towards Parent Company (Quarter)
0.37M5.57M-4.72M12.46M3.09M5.69M-2.01M0.72M-1.14M-4.08M6.55M-4.98M-92.35M-1855.63M-4.93M-5.60M-5.69M-6.18M-6.38M-6.22M
Preferred Dividend Payments (Quarter)
-1.34M1.56M26.38M1.36M1.36M1.38M1.41M1.24M1.25M1.26M1.15M1.35M
Net Income towards Common Stockholders (Quarter)
0.07M4.45M-3.43M2.49M18.03M-1.34M-11.48M-13.25M-0.81M1.36M-6.30M-7.60M-5.31M-7.34M-7.69M-6.24M-6.94M-7.75M-7.74M-5.70M
Additional items
EPS (Basic) (Quarter)
-0.13-1.13-1.31-0.080.13-0.50-0.41-0.27-0.37-0.41-0.29-0.32-0.35-0.33-0.08
EPS (Diluted) (Quarter)
-0.13-1.13-1.31-0.080.12-0.50-0.39-0.27-0.37-0.41-0.29-0.32-0.35-0.33-0.08
Shares Outstanding (Quarter)
10.12M10.12M10.12M10.12M10.21M12.55M18.60M19.60M19.62M18.79M21.33M21.38M21.85M23.26M68.93M
Shares Outstanding (Diluted) (Quarter)
10.12M10.12M10.12M10.12M11.22M12.55M19.60M19.60M19.62M18.79M21.33M21.38M21.85M23.26M68.93M
EBITDA (Quarter)
-1.07M-2.99M-0.96M-1.49M-0.90M-1.80M-2.91M-3.77M-4.48M-3.38M-6.72M-4.88M-4.85M-4.97M-4.55M-5.11M-5.07M-5.71M-6.38M-5.96M
Interest Expenses (Quarter)
1.09M0.65M0.10M8.80M0.70M-13.27M0.10M87.50M1,850.66M0.38M0.49M0.62M0.47M0.26M
Tax Rate (Quarter)
3.39%8.58%-74.78%53.97%-11.92%